TWiV 921: COVID-19 clinical update #124 with Dr. Daniel Griffin
In COVID-19 clinical update #124, Dr. Griffin discusses the results of a variant vaccine booster trial, the neutralization of variant sub-lineages by Novavax, the CDC\u2019s recommendation of Novavax\u2019s COVID-19 vaccine in adults, Paxlovid in patients who are immunocompromised and hospitalized, and inhaled fluticasone for outpatient treatment.
Subscribe (free):\xa0Apple Podcasts,\xa0Google Podcasts,\xa0RSS,\xa0email
Become a\xa0patron\xa0of\xa0TWiV!
Links for this episode- Variant\xa0vaccine boosters trial\xa0(medRxiv)
- Novavax\xa0triggers neutralization of variant sub-lineages (bioRxiv)
- CDC\xa0recommends\xa0Novavax (CDC)
- Paxlovid in patients\xa0who are immunocompromised and hospitalized (The Lancet)
- Inhaled Fluticasone\xa0for outpatient treatment (medRxiv)
- PAXLOVID patient eligibility\xa0screening checklist (FDA)
- Remdesivir fact sheet\xa0for providers (Veklury)\xa0
- Bebtelovimab fact sheet\xa0for providers (FDA)
- Contribute to\xa0FIMRC fundraiser at PWB
- Dr. Griffin\u2019s treatment guide (pdf)
- Letters read\xa0on TWiV 921
- Timestamps by Jolene. Thanks!
Intro music is by\xa0Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv